Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04829383
Title A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma (AB7)
Acronym AB7
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kristen Spencer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
New York University Clinical Cancer Center New York New York 10016 United States Details
DHR Health Institute for Research and Development Edinburg Texas 785329 United States Details
Univeristy of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field